Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft
BJU International · 2024
DOI: 10.1111/bju.16243 ↗Kurz gefasst
Editorial in der Zeitschrift BJU International, 2024. Verfasst von Eric Chung. Beteiligte Einrichtung: Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Erectile Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
There has been considerable interest in the role of regenerative technology in restoring erectile function as contemporary treatments for erectile dysfunction (ED), such as phosphodiesterase type 5 inhibitors (PDE5i) and intracavernosal injection (ICI) of vasoactive agents, do not reverse the underlying pathophysiology of ED and patients will continue to be dependent on these medications to achieve penile erections. The ability to regenerate key neurovascular structures responsible for penile erection is very exciting and certainly revolutionary. The idea of nerve grafting to re-establish neural connectivity between severed nerves has been around for several decades now [1]. While several studies have shown some benefits following interposition nerve grafting at the time of radical prostatectomy [2, 3], its actual longer-term outcomes and widespread clinical adoption remain to be seen [3, 4]. In contrast to the previously described sural nerve interposition autonomic-to-autonomic (between severed ends of the cavernous nerve) grafting, this innovative penile re-innervation technique utilises a somatic-to-autonomic neurorrhaphy with end-to-side nerve grafting, and two centres have published remarkable erectile function recovery with this technique [4]. Nonetheless, the reported high success rate of this innovative technique has not been replicated by other centres around the world. This interesting paper by Dangerfield and Coombs [5] highlights four different scenarios where a somatic-to-autonomic sural nerve grafting can restore erection. I read this paper with great interest and scepticism at the same time. It is important to take note of several important key points relating to these patients namely: (i) an older age group (aged 59–68 years), (ii) different ED mechanisms (such as post-TURP vs radical pelvic surgery vs radiation therapy), (iii) duration of ED (from 2 to 11 years post-prostatectomy), (iv) use of erectile medications preoperatively (two patients were using Trimix ICI therapy), and (v) state of erectile function recovery post-graft surgery (one patient had a spontaneous return of erection while two patients remained dependent on PDE5i drugs). While conceptually this unique somatic-to-autonomic nerve grafting is innovative, many questions remain unanswered including the exact mechanism of action and whether the recovery of erectile function can truly be this remarkable. This somatic-to-autonomic neurorrhaphy surgery involves bridging the femoral nerve to the dorsal nerve of the penis and the inner part of the corpus cavernosum using a harvested sural nerve graft in an end-to-side nerve grafting manner. This side-to-end neurorrhaphy requires the harvested nerve to provide budding or sprouting of the donor nerve axons to establish neural connectivity between a somatic nerve (femoral nerve) and an autonomic nerve (underlying cavernous nerve) in addition to re-establishing neural functional communications between genital nerve receptor centres and the central nerve centres. So, the question arises whether just ‘attaching’ a somatic nerve end to the corporal tissue (instead of directly onto the cavernous nerve) can result in neural connectivity and ensure in the appropriate release of neurohumoral signals by the cavernous nerve to induce penile erection. It is important to note that the neurotransmitter acetylcholine has different effects on the somatic and autonomic nervous systems too. Furthermore, it is doubtful whether erectile function recovery is even possible, as published studies have shown that significant irreversible corporal fibrosis would have occurred after 2 years following the onset of ED [4, 6]. Similarly, in the setting of radiation therapy, it is likely that surrounding nerves (be it somatic or autonomic nerves) and corporal tissue would be affected and hence, it is highly unlikely that a fibrosed penis with minimal or absent pertinent erectile neurovascular structures can spontaneously recover erectile function [6]. Indeed, this novel surgical technique needs proper evaluation with objective measurements of penile haemodynamics such as penile colour Duplex ultrasound and whether there is an adjunctive role in the concurrent administration of various growth factors, stem cells or platelet-rich plasma to enhance cavernous nerve regeneration [6]. Presently, it is important to exercise caution regarding this innovative somatic-to-autonomic nerve grafting technique given the potential hope (or hype) it can bring to this very vulnerable group of patients with medically refractory ED. Indeed, further studies into the molecular basis of this somatic-to-autonomic nerve grafting coupled with better-designed and larger multicentre trials to confirm if this successful outcome can be replicated elsewhere, are required for this innovative technique can be accepted as a new standard of care in ED treatment. None. None.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia.
- AndroUrology Centre, Brisbane, Queensland, Australia.
ORCID-Profile: Eric Chung
Zitieren
APA
Chung, E. (2024). Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft. BJU International. https://doi.org/10.1111/bju.16243
Vancouver
Chung E. Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft. BJU International. 2024. doi:10.1111/bju.16243
BibTeX
@article{Chung2024,
author = {Chung, Eric},
title = {Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft},
journal = {BJU International},
year = {2024},
doi = {10.1111/bju.16243}
}
EUVIMED